Phase 2 N=10 Efficacy of Polypodium Leucotomos Extract Decreasing UVA Premutagenic and Photoaging Markers
Aging · Skin Abnormalities
Primary: Change in Common Deletion (CD) Value in DNA of Skin Biopsy Sample — -84; 217 percent change
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=26 Four Methods of Pre-oxygenation
Respiratory Failure
Primary: Exhaled Oxygen Concentration — 72; 86; 54; 77 % FeO2
Phase 3 N=8 Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan
Severe Pulmonary Arterial Hypertension
Primary: Serious Adverse Events — 5; 3; 1; 1 participants
Phase 3 N=392 Efficacy and Safety of SPARC0921 in Subjects With Spasticity
Spasticity
Primary: Treatment Failure Rate — 36.1; 43.2 percentage of subjects — p=0.2062
N/A N=60 Clinical Validation of DACP Digital Design
Refractive Errors
Primary: Distance Visual Acuity (VA) (logMAR, OU) — -0.11; -0.12 logMAR
Phase 1 N=16 CAVATAK (CVA21) in Non-muscle Invasive Bladder Cancer (VLA-012 CANON)
Non-muscle Invasive Bladder Cancer
Primary: Incidence of Dose-limiting Toxicities Treatment-related Adverse Events. — 9; 6 Participants
N/A N=16 Effect of Kiwifruit on Gastrointestinal Fluid Distribution and Transit in Healthy Volunteers
Constipation · Diet Modification
Primary: Relaxation Time in Ascending Colon — 312; 256 seconds*minutes
N/A N=140 Dietary Education Intervention Impact on Dietary Protein Intake in PD
Dietary Modification
Primary: Normalized Protein Catabolic Rate (nPCR) — 1.038; 0.930 g/(kg*d)
N/A N=38 Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
Atrial Fibrillation
Primary: Change in Pre- and Post-atenolol Ventricular Rate Response After 5 Minutes of Exercise — -10; -13 beats per minute
Phase 2 N=244 A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients
Osteoarthritis, Knee
Primary: Numeric Rating Scale (NRS) Average Target Knee Pain Score at Week 26 — -1.7; -1.5; -1.3 score — p=0.4055
N/A N=974 Abnormal Plantar Pressure in Patients With Diabetes
Diabetes Complications
Primary: Abnormal Plantar Pressure Distribution — 80; 894 Participants
N/A N=44 Challenging the Inflammatory Response System in Insomnia Disorder
Insomnia
Primary: Inflammatory Response to Physiological Challenge- Change in Plasma Levels of IL-6 — 1.5013; 2.1626; 2.5911; 2.7269 pg/mL
N/A N=352 Brief Alcohol E-Interventions Study
Alcohol Drinking in College
Primary: Mean Drinks Per Day — .93; 1.15; .86; 1.38 Drinks per day — p=<.05
N/A N=22 A Clinical Study to Compare Professional Treatments for Dentinal Hypersensitivity
Dentinal Hypersensitivity
Primary: Change From Baseline Air Challenge — -0.55; -0.95 Units on a scale
Phase 1 N=6 Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled BVD-523 in Volunteers
Healthy
Primary: Pharmacokinetics of 14C-labeled BVD-523(Radioactivity in Whole Blood and Plasma) Tmax — 2.57 hr